Biocom - Life Sciences Association of California
Close
Call
Profile
San Diego  |   Los Angeles  |   Washington, DC  |   Tokyo
cONTENT bLOCK
Left
Left
https://www.biocom.org/servlet/servlet.ImageServer?id=015F0000005wo69IAA&oid=00DA0000000Kz7JMAS  

Biocom Venture Day with SR-one

 
When:
Wednesday, May 03 2017 - Wednesday, May 03 2017
8:00 AM - 5:00 PM

Add to Calendar America/Los_Angeles Biocom Venture Day with SR-one Looking to raise money? Want to have a one-on-one meeting with a well-regarded Venture Capitalist? Join us for our first exclusive Biocom Venture Day in Los Angeles with Rajeev Dadoo, Partner, SR-one. Biocom false MM/DD/YYYY

Where:
Biocom Los Angeles Office
444 South Flower Street, Suite 1780
Los Angeles, California 90071
Registration Deadline:
Wednesday, April 19 2017
12:00 PM
Register


Biocom Venture Day with SR-one

Interested in the latest developments in the venture capital market?  Looking to raise money?  Join us for our first exclusive Biocom Venture Day in Los Angeles with Rajeev Dadoo, Partner, SR-one.

How can you participate?

SR-one is interested in meeting with innovation-oriented companies working towards discovering new drugs, with novel modalities and novel mechanisms of action. 

All therapeutic areas are of interest - must have unmet medical needs in the area. Investment stage span from seed stage through Series stages (A/B/C/etc). 

If you would like to submit your company for review for the one-on-one meetings, please send a one page non-confidential executive summary to Oscar Rodarte at orodarte@biocom.org

Important Event Details: 
Event Date: Wednesday, May 3rd
Deadline to submit an application is Wednesday, April 19th 


About Rajeev Dadoo, PhD, Partner, S.R. One, Limited 



Rajeev joined SR One in 2003 and is an alum of the Kauffman Fellows Program. Rajeev has been involved with SR One’s investments in True North, Illuminoss, Avhana, Setpoint, iPierian, Cydex, Hypnion, Predix and Pinnacle.

In addition to his role at SR One, Rajeev spent time with the Competitive Excellence group within GSK working on company-wide strategic projects for GSKs Corporate Executive Team. Prior to SR One, Rajeev worked at Genentech, where his role included technology and clinical development, and at Bio-Rad Laboratories in a product development role. In addition, Rajeev has worked at Genome Therapeutics in the business development role. Rajeev was a co-founder of Unimicro Technologies, a company that was created to develop and commercialize instrumentation for biomedical analysis.

Rajeev received his BA degree in Chemistry and Mathematics from Knox College, his MBA from the Wharton School of the University of Pennsylvania, and his PhD in Chemistry from Stanford University.


In Partnership with: 


 

Planner

Oscar Rodarte
 

Sponsored By: